A service of

Neuberger Berman challenges NDC take-private, eyes bigger M&A role in Japan – APAC Morning Flash

Neuberger Berman’s (NB) pushback on the Nippon Dry Chemical (NDC) take-private by ALSOK/Carlyle is unlikely to alter the outcome, but it can be seen as a deliberate effort to position the firm as a credible, active player in Japan’s M&A landscape.

The global asset manager has requested NDC’s board and special committee to further review ALSOK/Carlyle’s JPY 3,730 p/s offer price, transaction process and protections for minority shareholders.

The Flash sees a 19.9% premium to pre-announcement and an 11.5x EV/TTM EBITDA as light, considering the offer emerged from a competitive process.

NB’s 7.16% stake, built in late May, makes it NDC’s second-largest shareholder after ALSOK (15.32%), yet it is still well short of a 10% threshold required to block a squeeze-out or exert meaningful leverage. Its ability to derail or materially reprice the ALSOK/Carlyle JPY 100bn (USD 633.7m) implied equity deal is therefore limited.

Shares of the fire safety solutions company initially traded above terms following NB’s 11 June statement but have since reverted to slightly below the offer price as the 29 June deadline approaches, suggesting little expectations of a higher offer despite NB’s pressure.

As NB did not continue to further build its stake, stopping a deal does not appear to be its objective. The Flash sees this as a reputational play aimed at building visibility and credibility in a relationship-driven market.

By publicly challenging the valuation and process, DCF assumptions, peer selection and the robustness of the market check, NB is marking a clear shift from passive ownership in Japan to active engagement.

The timing reinforces that message. Weeks earlier, NB partnered with Sumitomo Mitsui Banking Corporation (SMBC) to co-run a GP platform for domestic LBO lending, with a mandate to deepen financing capacity and support sponsor-led transactions in Japan.

In the Flash’s view, NB is using this situation to show it can do more than provide capital. It can underwrite, scrutinise and challenge deal dynamics. That matters in Japan, where credibility is built through active engagement rather than passive ownership. Ultimately, NB is positioning itself as both capital provider and governance actor, strengthening its standing with corporates, advisers, and boards as it seeks to differentiate itself in Japan’s still concentrated LBO and private debt market.

 

A closer look at Nippon Dry Chemical suggests fair value near JPY 4,500

NB has stopped short of assigning a specific intrinsic value for NDC but made a credible case that the ALSOK/Carlyle offer warrants a second look, given what it views as a flawed review process.

It argues the DCF assumptions are unduly conservative, peer comparables do not reflect NDC’s evolving business mix, and precedent premiums fail to capture the structural shift in Japan’s M&A environment. More critically, NB contends the valuation appears anchored to management’s medium-term plan targets and that the price discovery process was not sufficiently competitive.

NB questioned whether the assumptions for the DCF are reasonable with the favourable tailwinds from data centres and semiconductor-related demand, alongside management’s track record of under-forecasting earnings. It also challenged the peer set, noting the reliance on lower-multiple firefighting equipment names rather than construction and maintenance operators that better capture NDC’s business profile.

Meanwhile, the absence of a robust market check, with Carlyle ultimately joining as a co-bidder, also raises doubts about genuine price discovery.

A reassessment of the relevant domestic and global peers serving the mission-critical facilities and maintenance space suggest a median 16.3x EV/EBITDA multiple, implying about JPY 5,250 p/s in fair value for NDC. While these peers are much larger in size and scale, they’re trading at substantially higher multiples than the deal multiple – which implies a 41% upside should the terms be reassessed.

Domestic peers Kinden and Kandenko, identified by NB, trade at 13.8x and 13.7x, while global peers (Johnson Controls, APi Group) command 18.8x–21.9x. That said, with the absence of competing bidders and ALSOK’s strategic position, a more realistic outcome anchored to domestic valuation ranges implies a smaller upside of roughly 19% (JPY 4,450).

Nevertheless, Kinden’s JPY 85bn (USD 534m) takeover offer for electric contractor Kodensha provides a 198% premium to the undisturbed price and implies a valuation of 20.6x EV/TTM EBITDA. This provides a strong valuation case should NDC be valued as a mission-critical facility contractor.

Chart showing Nippon Dry Chemical stock performance

Equally important are process concerns. The premium analysis appears selectively framed using a limited dataset, while the final offer price was effectively anchored to a pre-existing market capitalisation target that does not incorporate a control premium. The latest 10 take-privates in Japan suggest a median premium of 91% to undisturbed price and 22% to pre-announcement price, according to Dealreporter data.

Nonetheless, without further minority shareholder activism, ALSOK/Carlyle’s take-private looks likely to proceed. The deal is subject to a minimum of 50.2% acceptance and will close on 29 June, unless extended.

 


This report should not be relied upon to make investment decisions. Furthermore, this report is not intended and should not be construed as investment advice. ION Analytics does not provide any investment advice, and clients should consult with their own financial advisor for matters requiring investment advice. All information is sourced from either the public domain or ION Analytics data or intelligence, and ION Analytics cannot and does not verify or guarantee the adequacy, accuracy or completeness of any source document. No representation is made that it is current, complete or accurate. The information herein is not intended to be used as a basis for investing and does not constitute an offer to buy or sell any securities or investment strategy. The information herein is for informational purposes only and ION Analytics accepts no liability whatsoever for any direct or consequential loss arising from any use of the information contained herein.